Clinical Research Directory
Browse clinical research sites, groups, and studies.
Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection
Sponsor: Elisabethinen Hospital
Summary
In order to secure the diagnosis of lung cancer, the investigator will perform a bronchoscopy in order to take tissue samples. These samples will be analyzed in the pathology. This is the routine standard. The aim of the study is to treat the lesion with a device that works both with cold and radiofrequency. The device is already in use for the treatment of lesions. The device allows direct treatment of the lesion during the routine bronchoscopy. As planned, the lesion will then be surgically removed. After the surgery the lesion will be analyzed in the pathology to show the effect of the use of the device. This additional treatment is safe and will support the treatment of the lesion. There are no additional steps or assessments for the participants to undergo.
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-05
Completion Date
2028-10
Last Updated
2026-04-15
Healthy Volunteers
No
Conditions
Interventions
Cryotherapy
Transbronchiual Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Staging and Resection
Locations (1)
Ordensklinikum Linz Elisabethinen
Linz, Austria